Evidence map›Paper›PMID 40937601›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2025

Real-Time Monitoring of Atherosclerotic Plaque Using β-Galactosidase-Activated Photoacoustic Tomography.

Yifan Zhou, Hang Yang, Handi Deng, Feng Zhang, Junjie Jiang, Sibo Yang, Xiaodi Sun, Jiehong Wu, Yanan Li, Huijuan Jin and 4 more

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yifan ZhouDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.
Hang YangDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.
Handi DengDepartment of Electronic Engineering, Beijing National Research Center for Information Science and Technology, Tsinghua University, Beijing, 100084, P. R. China.
Feng ZhangDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.
Junjie JiangDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.
Sibo YangDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.
Xiaodi SunDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.
Jiehong WuDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.
Yanan LiDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.
Huijuan JinDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.
Hao WangCAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), No. 11 Beiyitiao, Zhongguancun, Beijing, 100190, P. R. China.
Cheng MaDepartment of Electronic Engineering, Beijing National Research Center for Information Science and Technology, Tsinghua University, Beijing, 100084, P. R. China.
Li-Li LiSchool of Material Science and Engineering, Beijing Institute of Technology, Beijing, 100081, P. R. China.
Bo HuDepartment of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.ORCID 0000-0003-1462-8854

Funding

Core medical technology project of union hospital No.2024JBGS2008toB.HHubei Province Key R&D Program No.2022BCA008toB.HNational Key Research and Development Program of China grant2024YFC3044800toB.HNational Natural Science Foundation of China No.82330040toB.H,No.E3041101toL.L.L,No.82090044toB.H,No.82371341toY.F.Z,No.82427806toL.L.L,No.81820108010toB.HNoncommunicable Chronic Diseases-National Science and Technology Major Project grant2024ZD0527901toB.HYoung Elite Scientists Sponsorship Program by CAST No.2022QNRC001toY.F.Z
6 · The paper itself

Abstract

The early monitoring and risk assessment of atherosclerotic progression is crucial yet challenging due to its intricate and dynamic pathological process. A lipo-nanoprobe incorporating chlorophyll derivatives is developed, which enables enzyme-triggered in situ J-aggregation-induced red-shift, allowing detection at 710 nm with a linear relationship to senescence-associated β-galactosidase (SA-β-gal), an essential marker of atherosclerotic formation and progression. The photoacoustic histological analysis conducted using the nanoprobe confirmed the accurate visualization of plaque microenvironment SA-β-gal activity, enabling semi-quantitation of plaque progression at different time points. By employing dynamic multi-wavelength imaging, the nanoprobe presented a specific SA-β-gal-dependent absorption at 710 nm in vivo. Utilizing photoacoustic tomography imaging, 3D images of plaques were reconstructed and quantitative analysis was performed on the extent and distribution of senescence in the total aortic vascular wall. The monitored signal revealed significant trends in relation to cellular senescence phenotype, particularly in vascular smooth muscle cells (VSMCs), which are crucial for clinically assessing the impact of cellular processes that contribute to plaque formation and expansion during the progression of atherosclerosis. This study demonstrates the utility of SA-β-gal-responsive photoacoustic imaging for detecting plaque pathological progression and highlights its advantage for early monitor plaque formation in individuals at risk of developing atherosclerosis.

Indexed as

beta-GalactosidasePhotoacoustic TechniquesPlaque, AtheroscleroticTomographyAnimalsCellular SenescenceMicebeta-Galactosidaseatherosclerosisbioactivated in vivo assemblynanoprobephotoacoustic tomography imagingsenescence‐associated β‐galactosidase

Identifiers

PMID40937601
PMCPMC12590527

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.